CANCER THERAPY

POWERED BY YOU

SYNCROMUNE® IS AT THE FOREFRONT OF DEVELOPING NEW IMMUNOTHERAPIES DESIGNED TO HELP PATIENTS WHO PREVIOUSLY HAD LIMITED TREATMENT OPTIONS.  OUR DESIRE TO DEVELOP SOLUTIONS FOR PATIENTS WITH UNMET NEEDS DRIVES US EVERY DAY.

®

CANCER THERAPY

POWERED BY YOU

®

SYNCROMUNE® IS AT THE FOREFRONT OF DEVELOPING NEW IMMUNOTHERAPIES DESIGNED TO HELP PATIENTS WHO PREVIOUSLY HAD LIMITED TREATMENT OPTIONS.  OUR DESIRE TO DEVELOP SOLUTIONS FOR PATIENTS WITH UNMET NEEDS DRIVES US EVERY DAY.

PATIENT RESOURCES

The following are additional resources to learn more about immunotherapy, SYNC-T's™ initial indications (metastatic non-small cell lung cancer, breast, and prostate), as well as current SYNC-T™ trials.

  • CURRENT SYNC-T™ TRIALS
  • AMERICAN LUNG ASSOCIATION
  • NATIONAL CANCER INSTITUTE
  • AMERICAN CANCER SOCIETY
  • CANCER.NET
  • CURRENT SYNC-T™ TRIALS
  • AMERICAN CANCER SOCIETY
  • CDC
  • CANCER CARE
  • BREAST CANCER RESEARCH FOUNDATION
  • CURRENT SYNC-T™ TRIALS
  • PROSTATE CANCER FOUNDATION
  • NATIONAL CANCER INSTITUTE
  • CANCER CARE
  • ZERO CANCER

Disclaimers: The content on this website is intended for US healthcare professionals only. The compounds and their uses mentioned on this website are investigational and have not been determined safe and effective by the US Food and Drug Administration.

Syncromune™ © 2023   ·   Terms of Use   |   Privacy   |   Cookies